
==== Front
Rev Cardiovasc Med
Rev Cardiovasc Med
RCM
Reviews in Cardiovascular Medicine
1530-6550
2153-8174
IMR Press

10.31083/j.rcm2508290
S1530-6550(24)01349-8
Review
Advances in Surgical Treatments of Left Ventricular Aneurysms
Jia Jun-Hang 1 †
Fu Wei 1 †
Sun Yi-Ping 1
Chen Cong 1
Zhang Kui 1 * zhangkui725@hotmail.com

Dong Ran 1 * dongran6618@hotmail.com

Sellés Manuel Martínez Academic Editor
1Department of Cardiac Surgery, Beijing AnZhen Hospital, Capital Medical University, 100029 Beijing, China
*Correspondence: zhangkui725@hotmail.com (Kui Zhang); dongran6618@hotmail.com (Ran Dong)
†These authors contributed equally.

16 8 2024
8 2024
25 8 29028 11 2023
3 2 2024
20 2 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY 4.0 license.
Despite improvements in the early intervention of myocardial infarction (MI) in recent decades, left ventricular aneurysms (LVA) remain a major health concern, particularly in developing nations. The progression of MI can lead to the thinning of the myocardial wall and the formation of a ventricular wall bulge, characteristic of an LVA. Furthermore, cardiac magnetic resonance (CMR) has emerged as the gold standard for LVA diagnosis due to its superior imaging capabilities. Notably, surgical ventricular reconstruction (SVR) is an effective treatment for LVA, aiming to restore the normal volume and structure of the left ventricle, thereby improving cardiac function. However, the criteria for selecting patients for SVR treatment remains a subject of debate. This review focuses on the current understanding of surgical indications, procedures, and prognostic risk factors that influence outcomes in left ventricular reconstruction, highlighting the need for precise patient selection to optimize surgical benefits.

left ventricular aneurysm
surgical ventricular reconstruction
prognosis
==== Body
pmc1. Introduction

Despite advancements in cardiovascular interventional therapies, left ventricular aneurysms (LVA) remains a prevalent mechanical complication following transmural myocardial infarction. Consequently, this condition can not only impair both left ventricular systolic and diastolic dysfunction, but also damage its normal structure [1], potentially leading to complications such as ventricular thrombosis, arrhythmias, and heart failure. Our understanding of LVA pathology and diagnostic approaches has deepened, with the Surgical Treatment of Ischemic Heart Failure (STICH) [2] indicating no significant benefit from adding surgical ventricular reconstruction (SVR) to coronary-artery bypass grafting (CABG). This raises important questions about the necessity and approach to LVA treatment and the identification of patients likely to benefit from specific interventions. Currently, surgery is the primary treatment for LVA. However ongoing improvements in surgical techniques, exploration of interventional strategies, and a better understanding of prognostic factors are leading to improved patient outcomes.

2. The Classification and Pathophysiological Mechanism of LVA

A LVA is broadly defined as a segment of the ventricular wall that exhibits dyskinetic or akinetic behavior, contributing to a reduction in left ventricular ejection fraction (LVEF) [3]. Furthermore, LVAs can be classified into two main categories: true aneurysm and pseudoaneurysm (Table 1). True aneurysms are characterized by the replacement of myocardial tissue with by scar tissue following myocardial infarction (MI), leading to dilation and deformation during cardiac cycles. In contrast, pseudoaneurysm occur following a rupture in the ventricular wall, with the resultant blood being contained by the surrounding pericardium and thrombus, thereby forming a sac that remains connected to the ventricular cavity [4]. Functional ventricular aneurysms, a subset of true aneurysms, may develop if residual myocardium within the infarcted area remains viable. These aneurysms are notable for their indistinct boundary between infarcted and normal myocardium, bulging only during systole [5]. The incidence of functional aneurysms is on the rise, attributed to early initiation of thrombolytic therapy [6] and revascularization procedures [7]. Several studies have identified transmural MI without coronary collateral circulation as a primary factor in the development of ventricular aneurysms [8, 9, 10]. Furthermore, Klein et al. [11] found that ventricular dilatation and ventricular wall thinning in the ischemic area occur when the infarcted myocardium accounts for more than 20% of the ventricular perimeter. This condition exacerbates ventricular wall tension and increases myocardial oxygen demand, perpetuating a harmful cycle.

Table 1. Differences between true aneurysm and pseudoaneurysm.

Differences	True aneurysm	Pseudoaneurysm	
Characteristics	Width of the neck	Wide	Narrow	
Myocardial rupture	No	Yes	
The composition of the ventricular wall	Necrotic myocardium, fibrotic tissue or both	Fibrous pericardial tissue and/or blood clots	
Diagnose	Echocardiography	The ventricular wall in the lesion area became thin and dilated during systole (paradoxical motion)	The echo of the ventricular wall was interrupted in the lesion area, and blood flow was observed between the aneurysm and the ventricular cavity	
Cardiac magnetic resonance	The myocardium of the lesion was thin, and a lot of scar myocardium was formed; transmural enhancement	Obliteration of myocardial-pericardial interface and pericardial enhancement	
Treatment principles	Restore normal structure of left ventricular	Obliterate the neck of the pseudoaneurysm	
Treatment	Surgical ventricular reconstruction or percutaneous ventricular restoration (the Parachute device, the Revivent TC System)	Surgical ventricular reconstruction or septal occluders, ventricular septal defect occluders, and coils	

3. Imaging of LVA

Echocardiography stands as the primary diagnostic tool for ventricular aneurysms, offering detailed insights into aneurysm size, location, shape, wall motion and overall cardiac function [12]. Dobutamine stress echocardiography is also effective in identifying myocardial regions that, despite being affected by ischemia or infarction, retain the potential to recover function, known as viable myocardium [13]. Despite its widespread use, the technique’s accuracy, particularly with conventional two-dimensional ultrasound, heavily relies on the practitioner’s expertise, potentially leading to overlooked small ventricular aneurysms and mural thrombus [14]. In recent years, the development of real-time three-dimensional echocardiography (RT3DE) has notably enhanced the precision in assessing cardiac structure and function [15].

Cardiac magnetic resonance (CMR) excels in measuring cardiac volume and ejection fraction, outperforming other methods [16]. Moreover, its late gadolinium enhancement (LGE) is the gold standard for evaluating viable myocardium, surpassing dobutamine stress echocardiography and positron emission tomography and also proving effective in detecting mural thrombus [17, 18]. Additional CMR advantages include its non-invasive nature, absence of radiation, high repeatability, and superior spatial resolution, making it arguably the best imaging method for evaluating ventricular aneurysms [19]. However, longer examination times and limitations for patients with claustrophobia or ferromagnetic implants present practical challenges.

4. Surgical Strategy for LVA

The 2009 STICH trial [2], published in the New England Journal of Medicine, questioned the efficacy of SVR. While SVR significantly reduces left ventricular volume, there was no notable difference between the SVR+CABG group compared to the CABG-alone group in terms of symptom improvement, all-cause mortality, and rehospitalization for cardiovascular causes. However, the trial’s conclusions have been met with skepticism due to several limitations: (1) Patient recruitment challenges led to broadened inclusion criteria, allowing the enrollment of patients with left ventricular end-systolic volume index (LVESVI) <60% [20]. (2) The assessment of cardiac structure and function at baseline and follow-up utilized three different imaging methods: CMR, echocardiography, and computed tomography, introducing variability to the results [20]. (3) The trial did not include evaluations for viable myocardium, omitting a critical factor in determining the effectiveness of SVR [20]. (4) The multicenter nature of the study complicated the standardization of surgical approaches, a significant challenge given the intricacies of ventricular aneurysm surgery [20]. (5) The reduction rate in the left ventricular end-systolic volume was deemed insufficient, at only 19% [21]. Additionally, a retrospective analysis by Ma et al. [22] reported that in a cohort of 121 patients with LVA undergoing CABG-alone, patients experienced a perioperative MI and mortality rate of 1.5% and an overall 2-year postoperative patient survival rate of 91.6%. These studies suggests that CABG treatment without SVR does not contribute to the sustained expansion of LVA, supporting the feasibility of CABG as a standalone treatment for LVA.

In contrast, recent retrospective studies [23, 24, 25] have highlighted the benefits of SVR in patients with LVA, noting reduced left ventricular volume, return of normal left ventricular morphology, improved cardiac function, and reduced rates of cardiac readmission. Building on this, Yang et al. [26] investigated whether SVR and CABG could improve long-term outcomes in patients with ventricular aneurysm and heart failure (HF). In this study 130 patients were divided into either a combined CABG+SVR group or a CABG-alone group. Preoperative assessment of scarred myocardium and cardiac function were assessed using LGE-CMR, ensuring that both groups had comparable baseline conditions. After a median follow-up of 10 years, the CABG+SVR group exhibited a significantly lower rate of HF rehospitalization compared to the CABG-alone group (3.1% vs. 20.6%), suggesting that SVR, when added to CABG, may offer substantial long-term benefits for patients with LVA and HF.

Currently there are three main guidelines for the surgical treatment of ventricular aneurysm (Table 2). The 2022 American guidelines for the management of heart failure recommend SVR in conjunction with CABG for patients with intractable HF, large thrombus, or persistent arrhythmias caused by LVA, when other treatments fail or are not viable [27]. The 2021 American Association for Thoracic Surgery (AATS) Expert Consensus proposed that concurrent SVR with CABG is indicated for patients with no viable myocardium, dyskinesis >35% of the anterior wall, LVESVI ≥60 mL/m2 or an anticipated reduction in LVESVI of more than 30% through SVR [28]. This consensus is the first to use myocardial viability to assess ventricular aneurysm. However, it does not specify the location and extent of the viable myocardium. Finally, the 2018 European revascularization guidelines recommend performing SVR with CABG in patients with New York Heart Association (NYHA) functional class III/IV, large LVA or thrombus formation, arrhythmias arising from the aneurysm, and HF symptoms, with a recommended grade IIA, evidence level class C [29]. In contrast to the STICH study [2], all three guidelines or expert consensus recommended SVR+CABG as a surgical intervention for LVA.

Table 2. Guideline recommendations or consensus regarding surgical treatment of ventricular aneurysm.

Consensus or guidelines	COR	LOE	Indication	Surgical treatment	
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure	-	-	intractable HF, large thrombus, or persistent arrhythmias resulting from well-defined aneurysm or scar	CABG+SVR	
2021: The American Association for Thoracic Surgery Expert Consensus Document	IIa	B-R	absent viability, dyskinesis ≥35% of the anterior wall, and LVESVI ≥60 mL/m2, an SVR achieving a >30% reduction in LVESVI	CABG+SVR	
2018 ESC/EACTS Guidelines on myocardial revascularization	IIa	C	NYHA class III/IV, large LV aneurysm, large thrombus formation, or if the aneurysm is the origin of arrhythmias	CABG+LV aneurysmectomy	
COR, classes of recommendations; LOE, level of evidence; IIa, weight of evidence/opinion is in favor of usefulness/efficacy. B-R, data derived from moderate-quality randomized clinical trials or meta-analyses; C, consensus of experts and/or small studies, retrospective studies, and registries; AHA, American Heart Association; ACC, American College of Cardiology; HFSA, Heart Failure Society of America; HF, heart failure; CABG, coronary artery bypass graft; SVR, surgical ventricular reconstruction; ESC, European Society of Cardiology; EACTS, European Association for Cardio-Thoracic Surgery; NYHA, New York Heart Association; LV, left ventricular; LVESVI, left ventricular end-systolic volume index.

5. Surgical Treatment of LVA

For the treatment of LVA, the effect of drug therapy is limited, and the efficacy of percutaneous ventricular restoration (PVR) needs further study. At present, the primary treatment of ventricular aneurysm remains surgical operation [30]. SVR can restore the original structure and function of the left ventricle by resecting scarred myocardium, reducing left ventricular volume, and reconstructing the left ventricular conical structure [31]. Notably, the surgical treatment of LVA has more than 60 years of history [32]. The guiding principle of operation has evolved from the resection of ventricular aneurysms to the isolation of the infarct area, the reduction of left ventricular volume, and the restoration of the normal conical structure of the left ventricle [33]. The surgical procedure also developed from linear suture to patch plasty to reduce the left ventricular volume, and then to patch plasty to restore the direction of the left ventricular muscle fibers. An overview of major trials in the field can be seen in Table 3 (Ref. [32, 34, 35, 36, 37, 38, 39]).

Table 3. Surgical procedures and percutaneous intervention of LVA.

Treatment methods	Time	Number of patients	Perioperative mortality	Follow-up time	Survival rates	Characteristics	
Standard linear closure (Sandwich closure) [32]	1958	81	3.7%	5 y	71%	The first SVR procedure, used for small aneurysms	
Endoventricular circular patch plasty (EVCPP) [36]	1989	113	4.4%	5 y	73%	The most used SVR procedure	
Septal anterior ventricular exclusion (SAVE) [37]	2006	29	0	5 y	80.3%	Emphasized reconstruction of left ventricular morphology with volume reduction	
The horseshoe repair [38]	2008	15	0	6.9 m	93.3%	The absence of a patch that reduces left ventricular volume while maintaining left ventricular compliance	
Keep fibers orientation with Strip patch reshaping (KISS) [39]	2009	21	0	2 y	100%	Restore the anatomic fibers’ contiguity and orientation	
Percutaneous left ventricular restoration (Parachute) [35]	2011	31	0	3 y	93.5%	The most promising interventional therapy	
The Revivent myocardial anchoring system (REVIVENT-TC) [34]	2018	86	4.5%	1 y	90.6%	It requires the cooperation of a cardiologist and a cardiac surgeon	
SVR, surgical ventricular reconstruction; LVA, left ventricular aneurysms; y, year.

In 1958, Cooley et al. [32] performed the “Standard linear closure” or “Sandwich” closure of LVA under cardiopulmonary bypass (Fig. 1). The operation was conducted as follows: after cutting the aneurysm lengthwise and clearing the thrombus, the ventricular wall was removed parallel to the anterior descending artery, the scar tissue of 1–2 cm was retained and consolidated with two mats, a horizontal U-shaped suture was performed, followed by a vertical suture [32]. The technique has many advantages, including it’s simplicity and the avoidance of artificial materials in the ventricular cavity. The disadvantages include reduced functional ventricular cavity, non-geometric reconstruction, and failure to remove the infarcted portion of the ventricular septum from the cavity. The procedure is suitable for patients with a small aneurysm and a well-defined fibrous scar [40].

Fig. 1. Diagram of the Cooley technique.

In 1985, Jatene proposed the concept of left ventricular geometric reconstruction, in which twisted muscle fibers are restored to their normal position and orientation [41]. The procedure consisted of a longitudinal incision of the aneurysm, folding and suturing the aneurysm of the distal ventricular septum, and a purse-string suture at the junction of normal myocardium and scar tissue. If the wound diameter is less than 3 cm, the wound is closed by linear suture. Otherwise, the wound is closed by the patch method. Jatene outlined five key considerations for ventricular aneurysm surgery. (1) The extent of the infarct size; the infarct size is decided by the blood supply area of the culprit artery, the degree of stenosis, and the degree of collateral circulation. (2) Location of the infarct area; which portion of the wall is the infarct area and whether the interventricular septal is involved make a difference in surgical strategy. (3) Expansion of the infarcted area; there is no direct relationship between the infarct size and the expansion of the infarct area. (4) The state of the non-infarct area; the non-infarct area of the myocardium will directly affect the wall stress and overall ventricular systolic function. (5) Complications of the aneurysm; these include various arrhythmias, intraventricular thrombi, and papillary muscle dysfunction. Of the 508 patients who underwent the Jatene procedure in 1977–1983, the perioperative mortality was 4.3%, and the long-term mortality was 3.5%.

In 1989, Dor et al. [36] used an “Endoventricular circular patch plasty” (EVCPP) to treat ventricular aneurysms (Fig. 2). This technique involves the removal of a dyskinetic or akinetic myocardium, the fixation of a Dacron patch lined with a pericardium at the junction of viable and scar myocardial tissue, and simultaneous revascularization. This approach has several noted advantages: (1) It leaves the infarcted myocardium of the interventricular septum out to avoid its abnormal motion. (2) It reconstructs the left ventricular chamber in a normal state utilizing patch plasty, avoiding the disadvantage of a small left ventricle volume caused by linear suture technique after resectioning a giant aneurysm. (3) It preserves the anterior descending artery for bypass. (4) It does not need external prosthetic material, avoiding pericardial adhesions.

Fig. 2. Diagram of the Dor procedure.

The Dor procedure is still widely used today, and the surgical approach continues to evolve and improve. Menicanti L and Di Donato [42] enhanced this technique using preshaped elliptical balloons to control the postoperative volume of the left ventricle. This modification, along with transitioning from not using an intraventricular patch to the use of a patch, has led to improved patient outcomes [43]. Research indicates that strategies focusing on restoring the left ventricle’s shape rather than merely reducing its volume yield greater benefits for patients [44, 45]. Furthermore, the surgical goal has been refined to not only reconstruct the ventricle’s conical structure but also to reduce the LVESVI to below 70 mL/m2 [46].

In 2006, Isomura et al. [37] published the results of the septal anterior ventricular exclusion (SAVE), or “Pacopexy” procedure for ischemic cardiomyopathy (ICM) (Fig. 3). This method reconstructs the left ventricular chamber by suturing numerous mattress stitches along the exclusion line, extending from the apex to a septal site 1 cm below the aortic valve. While the Dor procedure emphasized the exclusion of the scarred myocardium and volume reduction, the SAVE procedure prioritized the reconstruction of left ventricular morphology with volume reduction. Postoperative left ventriculograms reveal that the SAVE procedure results in a more elliptically shaped left ventricle, contrasting with the more spherical shape seen after EVCPP. In particular, the study showed no difference in perioperative mortality with the SAVE procedure compared with the Dor procedure, with a 5-year survival rate of 80.3% in 29 patients after SAVE and 77.4% in 54 patients after the Dor procedure. Another recent study compared the long-term outcomes of patients after the Dor procedure and the SAVE procedure. The 10-year survival rates in the two groups were 70.4 ± 7.9% vs. 41.7 ± 7.2% (p < 0.05), respectively, and the rehospitalization rates for HF and cardiac death were 60.0 ± 8.6% vs. 28.8 ± 6.8% (p < 0.05), respectively [47]. In contrast to the original study, the updated data clearly shows the clinical efficacy of the Pacopexy treatment.

Fig. 3. Diagram of the “Pacopexy” procedure.

In 2008, Ferrazzi introduced “the horseshoe repair” technique for treating ventricular aneurysms, a technique characterized by the absence of a patch, which results in a decrease to the left ventricular volume while maintaining left ventricular compliance [38]. The procedure involves the placement of two horseshoe-shaped, semicircular, parallel purse strings into the scar tissue along the interventricular septum, one in the middle of the anterior papillary attachment and the other shifted 1 cm toward the apex. The first purse string is secured to achieve a conical shape, and the second is tightened to reshape the new apex. Importantly, the operation can reduce the transverse diameter of the left ventricle without shortening the longitudinal length. Furthermore, a study of 15 patients undergoing the horseshoe repair showed a survival rate of 93.3% at 6.9-months after the operation.

In 2009, Cirillo [39] adopted the “Keep fibers orientation with Strip patch reshaping” (KISS) procedure to restore the anatomic fibers’ contiguity and orientation, thus improving the contractile function of ischemic myocardium (Fig. 4). The key differences in the KISS procedure include: (1) utilization of a narrow and long patch with arrow-shaped ends; (2) elimination of the need for purse strings; (3) asymmetric suturing of the patch inside the ventricle. The length of the arrow-shaped patch is tailored to span from the site of the apical infarction to the aortic valve. The interventricular septum edge of the patch is sutured equidistantly along the basal border of the fibrotic septum (patch-tissue equivalence), and the lateral edge of the patch is sutured to the lateral wall at an unequal distance along the border of the normal and infarcted myocardium (patch-tissue mismatch). This procedure was performed on twenty-one patients with a follow-up period of 2 years, with all patients surviving, and a decreased LVESVI from 87.5 ± 27.9 mL/m2 to 35.2 ± 16.1 mL/m2. Left ventricular torsion, an essential parameter for assessment of left ventricular ejection function, increased from 2.5 ± 4.6 to 2.5 ± 4.6, indirectly suggesting that the myocardial bundle returned to normal physiological orientation after the KISS procedure.

Fig. 4. Diagram of the KISS procedure. KISS, Keep fibers orientation with Strip patch reshaping.

In addition to surgical methods, interventional techniques have been explored to treat ventricular aneurysms. In 2007, Otasevic et al. [48] pioneered the first percutaneous left ventricular restoration utilizing a parachute-like device known as the left ventricular partitioning device (VPD). This device is introduced into the left ventricle was expanded with a balloon dilator, isolating the akinetic or dyskinetic myocardium and subsequently reducing the left ventricular volume. The Parachute V trial, a prospective, multi-center, post-market, non-randomized, nested-control, observational study of the parachute implant system was unfortunately terminated in June 2017 [48].

Subsequently, the Revivent myocardial anchoring system was developed by US company BioVentrix. This consists of two anchoring devices and a connecting wire, allowing the exclusion of the aneurysm area by anchoring and drawing the anterior and septal walls together [49]. An updated version, known as the Revivent TC System, allows a less invasive implantation on the beating heart without needing a thoracotomy and cardiopulmonary bypass (Fig. 5) [34]. However, the safety and efficacy of the device still need to be confirmed by a large prospective randomized controlled trial. Another innovative approach involves combining the left ventricular assist device (LVAD) HeartMate 3 (Abbott) with a “double patch technique” in SVR. This technique can be used in patients with end-stage HF and LVA who are ineligible for heart transplantation [50].

Fig. 5. Diagram of the Revivent TC System.

Ventricular dysrhythmia is a major cause of reduced quality of life and elevate the risk of sudden cardiac death in individuals with LVA. However, complete resection of the aneurysm or SVR can reduce the risk of postoperative ventricular dysrhythmias in most patients [51, 52]. Methods for diagnosing ventricular dysrhythmias include signal-averaged electrocardiography (SAECG), Holter monitoring, and epicardial and endocardial mapping [53, 54]. Treatment options include implantable cardioverter-defibrillators, ventricular tachycardia (VT) ablation, and percutaneous ablation [55].

6. Prognostic Factors for SVR

Since the introduction of SVR, there has been a concerted effort to discern the factors influencing the prognosis of patients undergoing SVR, with the objective of pinpointing candidates most likely to benefit from the procedure. Currently, the most extensively studied factors include LVEF, LVESVI, NYHA class, mitral regurgitation (MR) grade, and restrictive filling pattern (RFP).

6.1 LVEF

The RESTORE (Reconstructive Endoventricular Surgery, returning Torsion Original Radius Elliptical shape to the left ventricle) group experience published in 2004 identified that an LVEF ≤30% was a risk factor for postoperative mortality in patients experiencing congestive HF following an anterior myocardial infarction [56]. Further supporting this, research by Wakasa et al. [57] pinpointed postoperative LVEF as a critical determinant of long-term survival, indicating that SVR+CABG improved survival benefits by increasing LVEF. Specifically, in patients with a postoperative LVESVI between 40–80 mL/m2, each 3.1% increase in LVEF was associated with a 21% reduction in mortality [57]. In 2023, Ma et al. [22] found that preoperative ventricular thrombosis and a LVEF <40% increased the incidence of major adverse cardiac and cerebrovascular events (MACCE), underscoring the significance of LVEF as a prognostic factor in the surgical treatment of heart failure.

6.2 LVESVI

The LVESVI is the most well-studied factor and has the closest relationship with patient prognosis following SVR [57]. The RESTORE study, not only verified the safety and efficacy of SVR surgery, but also served as a foundation for the design of the subsequent STICH trial [56], pinpointed an LVESVI ≥80 mL/m2 as a risk factor for postoperative mortality [56]. Furthermore, Suma et al. [58] also concluded that preoperative high LVESVI was a mortality risk factor, while age, inotropic drugs, and pulmonary hypertension were not statistically impactful.

A later subgroup analysis of the STICH trial published in 2009 demonstrated a distinct survival benefit from SVR+CABG over CABG alone in patients with a postoperative LVESVI ≤70 mL/m2 [59]. In 2010, Di Donato et al. [21] found increased mortality rates in patients with a postoperative LVESVI >60 mL/m2, consistent with the findings of Witkowski et al. [60]. In 2011, Skelley et al. [61] found that SVR successfully increased EF and relieved symptoms in patients with severe congestive HF, particularly noting that patients with a preoperative LVESVI between 80 and 120 mL/m2 may be ideal candidates for SVR procedures.

In the same year, a study by Isomura et al. [62] analyzed the relationship between the volume reduction rate after SVR and the long-term prognosis of ICM, concluding that SVR is most effective when the LV volume was decreased by more than 33% and LVESVI was brought down less than 90 mL/m2. Furthermore, in 2020, Cui et al. [47] found that a preoperative LVESVI ≥60 mL/m2 and an age ≥65 years were factors associated with increased risks of cardiac readmission and death. In conclusion, these findings underscore the critical role of high preoperative LVESVI or suboptimal volume reduction during SVR as risk factors marking a poor prognosis.

6.3 NYHA Functional Class

Several studies [23, 56, 63, 64] have identified that diagnosis with NYHA functional class III or IV is a risk factor for patients undergoing surgical interventions. Further work by Witkowski et al. [60] determined that advanced HF status was associated with increases in mortality and HF hospitalization rates during a 2-years of follow-up period following SVR.

6.4 Mitral Regurgitation Grade

Several studies have highlighted an MR of grade 2 + as a significant postoperative risk factor [22, 23, 65], with evidence suggesting that an MR ≥3 + is a risk factor for postoperative mortality [58]. Moreover, Sartipy et al. [66] extended this by demonstrating a direct correlation between the severity of MR and increased risk of long-term mortality and hospital readmission due to heart failure. Currently, most doctors use mitral valvuloplasty plus SVR to treat moderate to severe MR with LVA [67]. However, a study by Yin [68] in 2016 showed that patients with LVA and MR ≥3 + undergoing concurrent mitral valve repair did not experience a reduction in long-term mortality or the incidence of MACCE.

6.5 Diastolic Dysfunction

Diastolic dysfunction usually manifests as an increase in early to late diastolic filling pressure >2 or restrictive filling pattern (RFP) [69]. In 2007, the Italian scholar Menicanti et al. [23] first proposed RFP as a significant predictor of mortality following SVR. Subsequently in 2017, Furukawa et al. [70] supported these findings with results indicating that RFP was the only meaningful predictor of MACCE in patients with ICM undergoing SVR. Similarly, Marui et al. [71] found that preoperative RFP was a major predictor of cardiovascular mortality. Crucially, Fantini et al. [72] found that RFP could be ameliorated in approximately 50% of patients following SVR, which was associated with a thicker left ventricular posterior wall and higher relative wall thickness (RWT) prior to surgery. In 2022, Toso et al. [73] stratified the prognosis of patients with a biological marker’s level and RFP. From this study, he found RFP is a risk factor for poor prognosis in patients with ICM.

Beyond the previously discussed factors, several other indicators are associated with the prognosis of patients undergoing SVR. In 2017, Couperus et al. [74] identified preoperative right ventricular systolic dysfunction as an independent predictor of increased mortality in patients with ICM who underwent SVR. That same year, Yang et al. [75] found that patients with 6 or more scarred myocardial segments had a higher risk of all types of cardiovascular events. Additionally, Adhyapak et al. [76] suggested that a smaller RWT often indicates dilated left ventricular (LV) remodeling, which correlates with increased mortality and a higher risk of heart failure readmission in patients with ICM. Furthermore, Choi et al. [77] found that a lower preoperative sphericity index (SI) was associated with better survival following SVR. Moreover, SI continued to increase despite improved LVEF and LV volume reduction suggesting a complex relationships between LV morphology, function, and post-SVR patient prognosis.

7. Conclusions

With advancements in early percutaneous intervention, the incidence of LVA is expected to decline, yet it remains a significant health concern. Echocardiography stands out as the most accessible diagnostic tool for LVA, while CMR provides the most accurate diagnosis. The decision to combine SVR with CABG in patients with coronary artery disease and LVA is still a subject of debate. Nonetheless, accumulating evidence suggests that surgery is beneficial for a specific subset of patients with LVA. It is essential to identify patients who can benefit from SVR, as it will inform new surgical guidelines based on the prognostic factors influencing patient outcomes.

The evolution of our understanding and treatment strategies for ventricular aneurysms continue to grow. From the initial resection of the aneurysm to the implementation of SVR, which aims not just to reduce the left ventricular volume but also to restore the normal ventricle and orientation of the muscle fibers. Additionally, the exploration of minimally invasive interventional devices through clinical trials represents the forefront of innovation in this field.

Much of the recent research consists of retrospective studies, and the few randomized controlled trials that exist face challenges due to variability in SVR procedures and small patient populations. This highlights the ongoing need for well-designed, large-scale, multicenter, randomized controlled trials employing standardized surgical approaches to further refine and validate the best treatment protocols for patients with LVA.

Acknowledgment

The authors thank AiMi Academic Services (https://www.aimieditor.com) for English language editing and review services.

Author Contributions

JHJ, WF conceived of the idea of the review and drafted the manuscript. YPS, CC, KZ and RD revised the manuscript, and have made substantial contributions to conception and design. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for aspects of the work.

Ethics Approval and Consent to Participate

Not applicable.

Funding

This review was supported by grants from the National Natural Science Foundation of China (No. 82270408).

Conflict of Interest

The authors declare no conflict of interest.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

[1] Hrycek E Walawska-Hrycek A Szymański R Stoliński J Nowakowski P Żurakowski A Giant left ventricular inferior wall aneurysm as a late complication after myocardial infarction: A case report Echocardiography 2023 40 259 265 36597587
[2] Jones RH Velazquez EJ Michler RE Sopko G Oh JK O’Connor CM et al Coronary bypass surgery with or without surgical ventricular reconstruction The New England Journal of Medicine 2009 360 1705 1717 19329820
[3] Buckberg GD Defining the relationship between akinesia and dyskinesia and the cause of left ventricular failure after anterior infarction and reversal of remodeling to restoration The Journal of Thoracic and Cardiovascular Surgery 1998 116 47 49 9671896
[4] Damluji AA van Diepen S Katz JN Menon V Tamis-Holland JE Bakitas M et al Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association Circulation 2021 144 e16 e35 34126755
[5] Meizlish JL Berger HJ Plankey M Errico D Levy W Zaret BL Functional left ventricular aneurysm formation after acute anterior transmural myocardial infarction. Incidence, natural history, and prognostic implications The New England Journal of Medicine 1984 311 1001 1006 6482909
[6] Tikiz H Balbay Y Atak R Terzi T Genç Y Kütük E The effect of thrombolytic therapy on left ventricular aneurysm formation in acute myocardial infarction: relationship to successful reperfusion and vessel patency Clinical Cardiology 2001 24 656 662 11594411
[7] Chen JS Hwang CL Lee DY Chen YT Regression of left ventricular aneurysm after delayed percutaneous transluminal coronary angioplasty (PTCA) in patients with acute myocardial infarction International Journal of Cardiology 1995 48 39 47 7744537
[8] Meizlish JL Berger HJ Plankey M Errico D Levy W Zaret BL Functional left ventricular aneurysm formation after acute anterior transmural myocardial infarction. Incidence, natural history, and prognostic implications The New England Journal of Medicine 1984 311 1001 1006 6482909
[9] Forman MB Collins HW Kopelman HA Vaughn WK Perry JM Virmani R et al Determinants of left ventricular aneurysm formation after anterior myocardial infarction: a clinical and angiographic study Journal of the American College of Cardiology 1986 8 1256 1262 3782632
[10] Hirai T Fujita M Nakajima H Asanoi H Yamanishi K Ohno A et al Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction Circulation 1989 79 791 796 2924412
[11] Klein MD Herman MV Gorlin R A hemodynamic study of left ventricular aneurysm Circulation 1967 35 614 630 6024006
[12] Brown SL Gropler RJ Harris KM Distinguishing left ventricular aneurysm from pseudoaneurysm A review of the literature. Chest 1997 111 1403 1409 9149600
[13] Krahwinkel W Ketteler T Wolfertz J Gödke J Krakau I Ulbricht LJ et al Detection of myocardial viability using stress echocardiography European Heart Journal 1997 18 D111 D116 9183619
[14] Malik SB Chen N Parker RA 3rd Hsu JY Transthoracic Echocardiography: Pitfalls and Limitations as Delineated at Cardiac CT and MR Imaging Radiographics 2017 37 383 406 28212053
[15] Marsan NA Westenberg JJM Roes SD van Bommel RJ Delgado V van der Geest RJ et al Three-dimensional echocardiography for the preoperative assessment of patients with left ventricular aneurysm The Annals of Thoracic Surgery 2011 91 113 121 21172497
[16] Lloyd SG Buckberg GD Use of cardiac magnetic resonance imaging in surgical ventricular restoration European Journal of Cardio-Thoracic Surgery 2006 29 S216 S224 16564180
[17] Patel AR Salerno M Kwong RY Singh A Heydari B Kramer CM Stress Cardiac Magnetic Resonance Myocardial Perfusion Imaging: JACC Review Topic of the Week Journal of the American College of Cardiology 2021 78 1655 1668 34649703
[18] Weinsaft JW Kim HW Shah DJ Klem I Crowley AL Brosnan R et al Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction Journal of the American College of Cardiology 2008 52 148 157 18598895
[19] Fatehi Hassanabad A Ali IS Surgical ventricular restoration for patients with heart failure Reviews in Cardiovascular Medicine 2021 22 1341 1355 34957775
[20] Menicanti L Castelvecchio S Left ventricular reconstruction concomitant to coronary artery bypass grafting: when and how? Current Opinion in Cardiology 2011 26 523 527 21993355
[21] Di Donato M Castelvecchio S Menicanti L End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy European Journal of Heart Failure 2010 12 375 381 20185429
[22] Ma H Zhang SC Song YW Huang SY Zhao D Feng W Coronary artery bypass grafting alone for left ventricular aneurysm: A retrospective cohort study Advances in Cardiovascular Disease 2023 44 465 469
[23] Menicanti L Castelvecchio S Ranucci M Frigiola A Santambrogio C de Vincentiis C et al Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration The Journal of Thoracic and Cardiovascular Surgery 2007 134 433 441 17662785
[24] Prucz RB Weiss ES Patel ND Nwakanma LU Baumgartner WA Conte JV Coronary artery bypass grafting with or without surgical ventricular restoration: a comparison The Annals of Thoracic Surgery 2008 86 806 814 18721565
[25] Ferrell BE Jimenez DC Ahmad D Malkani K Rosen JL Gaw G et al Surgical ventricular reconstruction for ischemic cardiomyopathy-a systematic review and meta-analysis of 7,685 patients Annals of Cardiothoracic Surgery 2022 11 226 238 35733719
[26] Yang T Yuan X Li BT Gao W Du M et al Long-term Outcome After Coronary Artery Bypass Graft With Surgical Ventricular Reconstruction in Coronary Artery Disease Patients With Congestive Heart Failure and Left Ventricular Aneurysm Chinese Circulation Journal 2023 38 291 298
[27] Heidenreich PA Bozkurt B Aguilar D Allen LA Byun JJ Colvin MM et al 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Circulation 2022 145 e895 e1032 35363499
[28] Bakaeen FG Gaudino M Whitman G Doenst T Ruel M Taggart DP et al 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure The Journal of Thoracic and Cardiovascular Surgery 2021 162 829 850.e1 34272070
[29] Neumann FJ Sousa-Uva M Ahlsson A Alfonso F Banning AP Benedetto U et al 2018 ESC/EACTS Guidelines on myocardial revascularization European Heart Journal 2019 40 87 165 30165437
[30] Gong FF Vaitenas I Malaisrie SC Maganti K Mechanical Complications of Acute Myocardial Infarction: A Review JAMA Cardiology 2021 6 341 349 33295949
[31] Buckberg G Athanasuleas C Conte J Surgical ventricular restoration for the treatment of heart failure Nature Reviews. Cardiology 2012 9 703 716 23149831
[32] Cooley DA Collins HA Morris GC Jr Chapman DW Ventricular aneurysm after myocardial infarction; surgical excision with use of temporary cardiopulmonary bypass Journal of the American Medical Association 1958 167 557 560 13538738
[33] Castelvecchio S Pappalardo OA Menicanti L Myocardial reconstruction in ischaemic cardiomyopathy European Journal of Cardio-Thoracic Surgery 2019 55 i49 i56 31106339
[34] Klein P Anker SD Wechsler A Skalsky I Neuzil P Annest LS et al Less invasive ventricular reconstruction for ischaemic heart failure European Journal of Heart Failure 2019 21 1638 1650 31797492
[35] Costa MA Mazzaferri EL Jr Sievert H Abraham WT Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure: three-year outcomes of the PARACHUTE first-in-human study Circulation. Heart Failure 2014 7 752 758 25037310
[36] Dor V Saab M Coste P Kornaszewska M Montiglio F Left ventricular aneurysm: a new surgical approach The Thoracic and Cardiovascular Surgeon 1989 37 11 19 2522252
[37] Isomura T Horii T Suma H Buckberg GD Septal anterior ventricular exclusion operation (Pacopexy) for ischemic dilated cardiomyopathy: treat form not disease European Journal of Cardio-Thoracic Surgery 2006 29 S245 S250 16567109
[38] Ferrazzi P Triggiani M Iacovoni A Pentiricci S Vattimo F Parrella P et al Surgical ventricular restoration by means of a new technique to preserve left ventricular compliance: the horseshoe repair The Journal of Thoracic and Cardiovascular Surgery 2008 136 1382 1383 19026840
[39] Cirillo M A new surgical ventricular restoration technique to reset residual myocardium’s fiber orientation: the “KISS” procedure Annals of Surgical Innovation and Research 2009 3 6 19549296
[40] Hui DS Restrepo CS Calhoon JH Surgical Decision Making for Left Ventricular Aneurysmectomy The Annals of Thoracic Surgery 2020 110 e559 e561 32533932
[41] Jatene AD Left ventricular aneurysmectomy. Resection or reconstruction The Journal of Thoracic and Cardiovascular Surgery 1985 89 321 331 3974267
[42] Menicanti L Di Donato M The Dor procedure: what has changed after fifteen years of clinical practice? The Journal of Thoracic and Cardiovascular Surgery 2002 124 886 890 12407369
[43] Lundblad R Abdelnoor M Svennevig JL Surgery for left ventricular aneurysm: early and late survival after simple linear repair and endoventricular patch plasty The Journal of Thoracic and Cardiovascular Surgery 2004 128 449 456 15354107
[44] Calafiore AM Iacò AL Amata D Castello C Varone E Falconieri F et al Left ventricular surgical restoration for anteroseptal scars: volume versus shape The Journal of Thoracic and Cardiovascular Surgery 2010 139 1123 1130 20412951
[45] Di Mauro M Iacò AL Bencivenga S Clemente D Marcon S Asif M et al Left ventricular surgical remodelling: is it a matter of shape or volume? European Journal of Cardio-Thoracic Surgery 2015 47 473 479 24801340
[46] Menicanti LA Reduce or reshape, this is the question! European Journal of Cardio-Thoracic Surgery 2015 47 480 481 24994753
[47] Cui H Wu Y Wei S Gao C Jiang S The Pacopexy procedure for left ventricular aneurysm: a 10-year clinical experience Surgery Today 2020 50 134 143 31515619
[48] Otasevic P Sagic D Antonic Z Nikolic SD Khairakhan A Radovancevic B et al First-in-man implantation of left ventricular partitioning device in a patient with chronic heart failure: twelve-month follow-up Journal of Cardiac Failure 2007 13 517 520 17826641
[49] von Bardeleben RS Wenzel P Ruf TF Kreidel F Münzel T Beiras-Fernandez A Transcatheter left ventricular reshape of apical ischaemic aneurysm achieves left ventricular remodelling, improves wall motion, causes papillary muscle approximation, and a reduction of secondary MVR European Heart Journal 2020 41 3862 32691040
[50] Piperata A Kalscheuer G Pernot M Albadi W Metras A Peltan J et al Left ventricle reconstruction and heartmate3 implantation. The “double patch technique” Journal of Cardiac Surgery 2020 35 3116 3119 32949043
[51] Waldo AL Arciniegas JG Klein H Surgical treatment of life-threatening ventricular arrhythmias: the role of intraoperative mapping and consideration of the presently available surgical techniques Progress in Cardiovascular Diseases 1981 23 247 264 7008078
[52] Grossi EA Chinitz LA Galloway AC Delianides J Schwartz DS McLoughlin DE et al Endoventricular remodeling of left ventricular aneurysm. Functional, clinical, and electrophysiological results Circulation 1995 92 II98 100 7586470
[53] Kulakowski P Dluzniewski M Budaj A Ceremuzynski L Relationship between signal-averaged electrocardiography and dangerous ventricular arrhythmias in patients with left ventricular aneurysm after myocardial infarction European Heart Journal 1991 12 1170 1175 1782944
[54] Wiener I Mindich B Pitchon R Determinants of ventricular tachycardia in patients with ventricular aneurysms: results of intraoperative epicardial and endocardial mapping Circulation 1982 65 856 861 7074747
[55] Guandalini GS Liang JJ Marchlinski FE Ventricular Tachycardia Ablation: Past, Present, and Future Perspectives JACC. Clinical Electrophysiology 2019 5 1363 1383 31857035
[56] Athanasuleas CL Buckberg GD Stanley AWH Siler W Dor V DiDonato M et al Surgical ventricular restoration: the RESTORE Group experience Heart Failure Reviews 2004 9 287 297 15886974
[57] Wakasa S Matsui Y Kobayashi J Cho Y Yaku H Matsumiya G et al Estimating postoperative left ventricular volume: Identification of responders to surgical ventricular reconstruction The Journal of Thoracic and Cardiovascular Surgery 2018 156 2088 2096.e3 30195600
[58] Suma H Tanabe H Uejima T Isomura T Horii T Surgical ventricular restoration combined with mitral valve procedure for endstage ischemic cardiomyopathy European Journal of Cardio-Thoracic Surgery 2009 36 280 284 19394851
[59] Michler RE Rouleau JL Al-Khalidi HR Bonow RO Pellikka PA Pohost GM et al Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction The Journal of Thoracic and Cardiovascular Surgery 2013 146 1139 1145.e6 23111018
[60] Witkowski TG ten Brinke EA Delgado V Ng ACT Bertini M Marsan NA et al Surgical ventricular restoration for patients with ischemic heart failure: determinants of two-year survival The Annals of Thoracic Surgery 2011 91 491 498 21256300
[61] Skelley NW Allen JG Arnaoutakis GJ Weiss ES Patel ND Conte JV The impact of volume reduction on early and long-term outcomes in surgical ventricular restoration for severe heart failure The Annals of Thoracic Surgery 2011 91 104 111 21172496
[62] Isomura T Hoshino J Fukada Y Kitamura A Katahira S Kondo T et al Volume reduction rate by surgical ventricular restoration determines late outcome in ischaemic cardiomyopathy European Journal of Heart Failure 2011 13 423 431 21317149
[63] Athanasuleas CL Buckberg GD Stanley AWH Siler W Dor V Di Donato M et al Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation Journal of the American College of Cardiology 2004 44 1439 1445 15464325
[64] Di Donato M Frigiola A Benhamouda M Menicanti L Safety and efficacy of surgical ventricular restoration in unstable patients with recent anterior myocardial infarction Circulation 2004 110 II169 II173 15364858
[65] Pocar M Di Mauro A Passolunghi D Moneta A Alsheraei AMTA Bregasi A et al Predictors of adverse events after surgical ventricular restoration for advanced ischaemic cardiomyopathy European Journal of Cardio-Thoracic Surgery 2010 37 1093 1100 20060737
[66] Sartipy U Albåge A Lindblom D Risk factors for mortality and hospital re-admission after surgical ventricular restoration European Journal of Cardio-Thoracic Surgery 2006 30 762 769 17027277
[67] Hobbs RD Assi A Bolling SF Patel HJ Deeb GM Romano MA et al Long-Term Survival and Echocardiographic Findings After Surgical Ventricular Restoration The Annals of Thoracic Surgery 2019 107 1754 1760 30586580
[68] Zhaohua Y Wei F Fei X Jiqiang Z Junzhe D Yangwu S Concomitant CABG, Left Ventricular Restoration and Mitral Valve Repair for Ischemic Heart Disease The Heart Surgery Forum 2016 19 E272 E275 28054895
[69] Yu CM Sanderson JE Shum IO Chan S Yeung LY Hung YT et al Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern European Heart Journal 1996 17 1694 1702 8922918
[70] Furukawa K Yano M Nakamura E Matsuyama M Nishimura M Kawagoe K et al Effect of preoperative left ventricular diastolic dysfunction on mid-term outcomes after surgical ventricular restoration for ischemic cardiomyopathy General Thoracic and Cardiovascular Surgery 2017 65 381 387 28374271
[71] Marui A Nishina T Saji Y Yamazaki K Shimamoto T Ikeda T et al Significance of left ventricular diastolic function on outcomes after surgical ventricular restoration The Annals of Thoracic Surgery 2010 89 1524 1531 20417772
[72] Fantini F Toso A Menicanti L Moroni F Castelvecchio S Restrictive filling pattern in ischemic cardiomyopathy: Insights after surgical ventricular restoration The Journal of Thoracic and Cardiovascular Surgery 2021 161 651 660 31767363
[73] Toso A Castelvecchio S Menicanti L Volpe M Fantini F Prognostic value of natriuretic peptides and restrictive filling pattern before surgical ventricular restoration The Journal of Thoracic and Cardiovascular Surgery 2022 164 1092 1101.e1 33168168
[74] Couperus LE Delgado V Palmen M van Vessem ME Braun J Fiocco M et al Right ventricular dysfunction affects survival after surgical left ventricular restoration The Journal of Thoracic and Cardiovascular Surgery 2017 153 845 852 27751580
[75] Yang T Lu M Ouyang W Li B Yang Y Zhao S et al Prognostic value of myocardial scar by magnetic resonance imaging in patients undergoing coronary artery bypass graft International Journal of Cardiology 2021 326 49 54 33296720
[76] Adhyapak SM Parachuri VR Thomas T Varghese K Left ventricular function and survival in ischemic cardiomyopathy: Implications for surgical ventricular restoration JTCVS Open 2021 7 211 218 36003693
[77] Choi JO Daly RC Lin G Lahr BD Wiste HJ Beaver TM et al Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow-up from the STICH trial European Journal of Heart Failure 2015 17 453 463 25779355
